Fred Alger Management’s Tango Therapeutics TNGX Stock Holding History

Fred Alger Management’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.16M	Sell	69,038 -81,032	-54%	-$2M	0.01%	310
2026 Q1	$3.14M	Buy	+150,070	New	+$2.09M	0.01%	276
2025 Q4	–	Sell	-230,316	Closed	-$1.93M	–	510
2025 Q3	$1.93M	Buy	230,316 +38,979	+20%	+$264K	0.01%	323
2025 Q2	$980K	Buy	+191,337	New	+$473K	﹤0.01%	356
2023 Q4	–	Sell	-47,337	Closed	-$533K	–	496
2023 Q3	$533K	Buy	+47,337	New	+$289K	﹤0.01%	378

Other funds holding TNGX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Fred Alger Management's TNGX Position: Q2 2026 in Review

Fred Alger Management reduced its Tango Therapeutics (TNGX) stake by 54% in Q2 2026, selling an estimated $2M and leaving 69,038 shares worth $2.16M. The position accounts for 0.01% of the portfolio, ranked #310.

Fred Alger Management first reported a position in TNGX in Q3 2023 and has held it in 5 quarters since. The position peaked at $3.14M in Q1 2026. 249 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

Fred Alger Management held 69,038 shares of Tango Therapeutics worth $2.16M as of Q2 2026.
Fred Alger Management sold 81,032 Tango Therapeutics shares in Q2 2026, an estimated $2M.
Tango Therapeutics made up 0.01% of Fred Alger Management's portfolio in Q2 2026, its #310 holding.
Fred Alger Management first reported a position in Tango Therapeutics in Q3 2023 and has held it in 5 quarters since.
Fred Alger Management's Tango Therapeutics position peaked at $3.14M in Q1 2026.
249 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.